Furthermore, we demonstrate that gene therapy using AAV9‐mediated HIPK1 knockdown is protective against pathological cardiac hypertrophy through inhibiting CREB and that inhibition of HIPK1 and CREB forms a synergistic pathway in preventing pathological cardiac hypertrophy. This evidence concerns the gene CREB1 and cardiac hypertrophy.